These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 35789865)

  • 21. Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking.
    Saeed M; Kadioglu O; Khalid H; Sugimoto Y; Efferth T
    J Nutr Biochem; 2015 Jan; 26(1):44-56. PubMed ID: 25459885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multidrug resistance: molecular mechanisms and clinical relevance.
    Ling V
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies.
    Mora Lagares L; Minovski N; Caballero Alfonso AY; Benfenati E; Wellens S; Culot M; Gosselet F; Novič M
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier.
    Eisenblätter T; Hüwel S; Galla HJ
    Brain Res; 2003 May; 971(2):221-31. PubMed ID: 12706238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterial multidrug resistance mediated by a homologue of the human multidrug transporter P-glycoprotein.
    Konings WN; Poelarends GJ
    IUBMB Life; 2002; 53(4-5):213-8. PubMed ID: 12120998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P-glycoproteins: mediators of multidrug resistance.
    Germann UA; Pastan I; Gottesman MM
    Semin Cell Biol; 1993 Feb; 4(1):63-76. PubMed ID: 8095827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of multidrug resistance by pro-inflammatory cytokines.
    Ho EA; Piquette-Miller M
    Curr Cancer Drug Targets; 2006 Jun; 6(4):295-311. PubMed ID: 16848721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shedding light on drug transport: structure and function of the P-glycoprotein multidrug transporter (ABCB1).
    Sharom FJ
    Biochem Cell Biol; 2006 Dec; 84(6):979-92. PubMed ID: 17215884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of phase I, II and III drug metabolism/transport by xenobiotics.
    Xu C; Li CY; Kong AN
    Arch Pharm Res; 2005 Mar; 28(3):249-68. PubMed ID: 15832810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular analysis of the multidrug transporter, P-glycoprotein.
    Germann UA; Chambers TC
    Cytotechnology; 1998 Sep; 27(1-3):31-60. PubMed ID: 19002782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2).
    Litman T; Brangi M; Hudson E; Fetsch P; Abati A; Ross DD; Miyake K; Resau JH; Bates SE
    J Cell Sci; 2000 Jun; 113 ( Pt 11)():2011-21. PubMed ID: 10806112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the kinetics of active efflux of 99mTc-MIBI in cells with P-glycoprotein-mediated and multidrug-resistance protein-associated multidrug-resistance phenotypes.
    Vergote J; Moretti JL; de Vries EG; Garnier-Suillerot A
    Eur J Biochem; 1998 Feb; 252(1):140-6. PubMed ID: 9523723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidrug resistance genes and p-glycoprotein in the testis of the rat, mouse, Guinea pig, and human.
    Melaine N; Liénard MO; Dorval I; Le Goascogne C; Lejeune H; Jégou B
    Biol Reprod; 2002 Dec; 67(6):1699-707. PubMed ID: 12444043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in molecular modeling and medicinal chemistry aspects of phospho-glycoprotein.
    Srinivas E; Murthy JN; Rao AR; Sastry GN
    Curr Drug Metab; 2006 Feb; 7(2):205-17. PubMed ID: 16472108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenosine triphosphate-binding cassette transporters mediate chemokine (C-C motif) ligand 2 secretion from reactive astrocytes: relevance to multiple sclerosis pathogenesis.
    Kooij G; Mizee MR; van Horssen J; Reijerkerk A; Witte ME; Drexhage JA; van der Pol SM; van Het Hof B; Scheffer G; Scheper R; Dijkstra CD; van der Valk P; de Vries HE
    Brain; 2011 Feb; 134(Pt 2):555-70. PubMed ID: 21183485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of multidrug transporters in drug availability, metabolism and toxicity.
    Bodó A; Bakos E; Szeri F; Váradi A; Sarkadi B
    Toxicol Lett; 2003 Apr; 140-141():133-43. PubMed ID: 12676459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution.
    Baldini N; Scotlandi K; Serra M; Shikita T; Zini N; Ognibene A; Santi S; Ferracini R; Maraldi NM
    Eur J Cell Biol; 1995 Nov; 68(3):226-39. PubMed ID: 8603675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1).
    He SM; Li R; Kanwar JR; Zhou SF
    Curr Med Chem; 2011; 18(3):439-81. PubMed ID: 21143116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulfocoumarins, specific carbonic anhydrase IX and XII inhibitors, interact with cancer multidrug resistant phenotype through pH regulation and reverse P-glycoprotein mediated resistance.
    Podolski-Renić A; Dinić J; Stanković T; Jovanović M; Ramović A; Pustenko A; Žalubovskis R; Pešić M
    Eur J Pharm Sci; 2019 Oct; 138():105012. PubMed ID: 31330259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and function of p-glycoprotein in normal tissues: effect on pharmacokinetics.
    Staud F; Ceckova M; Micuda S; Pavek P
    Methods Mol Biol; 2010; 596():199-222. PubMed ID: 19949926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.